Table of Contents 1 Basic Concepts of Sorafenib 1.1 Indications 1.2 Development History of Sorafenib in China 1.3 Registration Information of Sorafenib in China 2 Sales of Sorafenib in China, 2013-2017 2.1 Overall Sales of Sorafenib in China 2.1.1 Sales Value 2.1.2 Sales Volume 2.2 Sales of Sorafenib in China by Region 2.2.1 Sales Value by Region 2.2.2 Sales Volume by Region 2.3 Sales of Sorafenib by Dosage Form 3 Analysis on Major Sorafenib Manufacturers in China 3.1 Bayer 3.2 Indian Enterprises 3.3 Progress of China-made Generic Drugs 4 Prices of Sorafenib in China, 2017-2018 4.1 Bayer (Product Trade Name: NATCO) 4.2 Generic Drugs Smuggled from India 5 Prospects of Chinese Sorafenib Market, 2018-2022 5.1 Forecast on Market Size 5.2 Forecast on Competition Pattern Selected Charts Chart Governmental Approval of Sorafenib in China Chart Sales Value of Sorafenib Legally Sold in China, 2013-2017 Chart Sales Value of Sorafenib in Parts of China, 2013-2017 Chart Sales Volume of Sorafenib in China, 2013- 2017 Chart Sales Volume of Sorafenib in Parts of China, 2013-2017 Chart Market Share of Sorafenib Manufacturers by Sales Value in China, 2013-2017 Chart Market Share of Sorafenib Manufacturers by Sales Volume in China, 2013-2017 Chart Sales Value and Market Share of Sorafenib Tablets in China, 2013-2017 Chart Sales Volume and Market Share of Sorafenib Tablets in China, 2013-2017 Chart Prices of Bayer's Sorafenib in Several Chinese Cities, 2017-2018

Bayer